Clinical Trial Update: Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections [Phase 4]

View source ↗

Summary

Phase 4 trial update on DEXTENZA for pain and inflammation in patients receiving intravitreal anti-VEGF injections; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Retina Vitreous Associates of Florida | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 4 | Status: TERMINATED